Lupus · 2011 · 47 citations · 36 references
MedicineHematologyNeurologyAutoimmunityEpilepsyNeuroimmunologyAntiphospholipid SyndromeCerebrovascular DiseaseEpilepsy SyndromesMultiple SclerosisStrokeSystemic Lupus ErythematosusAnti-beta-2 Glycoprotein I AntibodiesAnti-phospholipid AntibodiesAntibodiesIschemic Stroke PathologyIschemic Stroke PathophysiologyIschemic Stroke PrognosticationRecurrent Stroke PreventionSystemic Lupus Erythematosus Associations
This report discusses the difference between antiphospholipid antibodies (aPL) as a predictor for first and recurrent ischemic stroke, whether or not concomitant systemic lupus erythematosus (SLE) increases aPL-associated risk, and the association of aPL with other neurological manifestations. The neurological manifestations covered in this report were selected because they are among the most common, including cognitive dysfunction, headache, multiple sclerosis and seizures/epilepsy. Recommendations are made regarding further research that is needed to clarify remaining uncertainties.
36
Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period
Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine · 2003 · 1.4K citations · Full text
Medicine, Nephrology, Autoimmunity +10